La chaîne d'options affiche les données clés des options sur actions de iBio à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour iBio..

iBio (NASDAQ:IBIO) Stock, Chaîne d'Options

IBIO INC

iBio

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

iBio Inc

News

Health Care

Press Releases

General

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

iBio Announces Proposed Public Offering

iBio Announces Pricing of $50 Million Public Offering

iBio Announces Closing of $50 Million Public Offering

Earnings

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

IBIO

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals

AlphaTON Capital

Boundless Bio

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Elutia

enGene Holdings

Enlivex Therapeutics Ltd. - Ordinary Shares

Enlivex Therapeutics

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Leap Therapeutics

Mural Oncology

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

Nanoviricides

NeuroSense Therapeutics Ltd. - Ordinary Shares

NeuroSense Therapeutics

NextCure

Pluri

Q32 Bio

Rallybio

Rein Therapeutics

SAB Biotherapeutics

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Tenax Therapeutics

Exicure

Oppenheimer

Leerink Partners

Chardan Capital

LUCID CAPITAL MARKETS

Brookline Capital

Comments

iBio

iBio (IBIO) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL